First “C-Kit-Positive” Cardiac Stem Cell Infusion Performed at Jewish Hospital
A team of researchers and physicians in Louisville performed the world’s first phase-one, FDA-approved clinical trial using “c-kit-positive” adult cardiac stem cells to treat heart disease. The clinical trial is being conducted by a team of University of Louisville physicians at Jewish Hospital, in collaboration with Dr. Piero Anversa and his team at Brigham and Women’s Hospital, Boston, MA. Study participants are injected with their own cardiac stem cells. The cells are injected into heart scar tissue using a minimally-invasive cardiac catheterization procedure. Study participants will be monitored to determine if the stem cells help their hearts regenerate their own tissue and improve heart function. For more information, contact Barbara Mackovic, mailto: email@example.com.